Knowledge base and emerging trends in YAP1 research

被引:0
|
作者
Xu, Rong [1 ,2 ,3 ]
Yang, Zhiying [1 ,2 ,3 ,4 ]
Fan, Jiahui [1 ,2 ,3 ]
Huang, Xueying [1 ,2 ,3 ]
Long, Linna [1 ,2 ,3 ]
Yu, Siying [1 ,2 ,3 ]
Zhang, Xiaorui [1 ,2 ,3 ]
Li, Xia [3 ,5 ]
Huang, He [1 ,2 ,3 ,5 ]
机构
[1] Cent South Univ, Canc Res Inst, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Sch Med, Dept Histol & Embryol, Changsha, Hunan, Peoples R China
[4] Changsha Hlth Vocat Coll, Changsha, Hunan, Peoples R China
[5] Xinjiang Med Univ, Affiliated Hosp 2, Sch Preclin Med, State Key Lab Pathogenesis Prevent & Treatment Hig, Urumqi, Xinjiang, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
YAP1; hippo signaling pathway; bibliometric analysis; citation burstiness; CiteSpace; VOSviewer; ORGAN SIZE CONTROL; HIPPO PATHWAY; BIBLIOMETRIC ANALYSIS; SIGNALING PATHWAY; CITED ARTICLES; YAP/TAZ;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Yes-associated protein 1 (YAP1) is a transcriptional coactivator that mediates the Hippo signaling pathway, which participates in the development and growth of the body; it plays key roles in tumorigenesis, metastasis, and therapy resistance. However, the pathophysiological mechanism of YAP1 has not been fully elucidated. Therefore, we explored the status and evolutionary trend in YAP1 research via bibliometric analysis. A total of 2,928 publications were downloaded from Web of Science Core Collection (WOSCC). The co-citation network map was drawn via CiteSpace and VOSviewer software. We analyzed the co-authorship networks among countries, journals, and authors, as well as co-occurrence of co-cited references, citation bursts, and keywords in YAP1 research, in order to predict its literature development. The present research evaluates the annual publication trends of YAP1 literature, and the following results were established: research on YAP1 are of steady increase; China present the highest co-citation; the Journal of Biological Chemistry (J Biol Chem) was the most productive journal, while Cell press received the most citations from co-cited references; Among the authors in the overall citations Bin Zhao is the most promising collaborator for emerging scholars in this field; and lastly, co-occurrence keyword analysis indicated that the emergingt rends in YAP1 research were mainly focused on cancer therapy. We established that projects on YAP1 research is presently in its rapid developmental stage with active global collaboration. In addition, the mechanism and clinical significance of YAP1 in cancer was established as the potential trend of future studies.
引用
收藏
页码:6467 / 6483
页数:17
相关论文
共 50 条
  • [21] YAP1 Expression in Different Subtypes of Rhabdomyosarcoma
    Siddiqi, Ahsan
    Habeebu, Sultan
    Tsokos, Maria
    Ahmed, Atif
    LABORATORY INVESTIGATION, 2017, 97 : 24A - 24A
  • [22] The RAS and YAP1 dance, who is leading?
    Corbo, Vincenzo
    Ponz-Sarvise, Mariano
    Tuveson, David A.
    EMBO JOURNAL, 2014, 33 (21): : 2437 - 2438
  • [23] YAP1 expression in Merkel Cell Carcinoma
    Sykaras, A.
    Kyriakopoulos, G.
    Kazamias, G.
    Stamou, C.
    Pantelakos, S.
    Dolkiras, P.
    Kouvidou, C.
    VIRCHOWS ARCHIV, 2019, 475 : S29 - S29
  • [24] YAP1 oncogene and its eight isoforms
    M Sudol
    Oncogene, 2013, 32 : 3922 - 3922
  • [25] Requirement for YAP1 signaling in myxoid liposarcoma
    Trautmann, Marcel
    Cheng, Ya-Yun
    Jensen, Patrizia
    Azoitei, Ninel
    Brunner, Ines
    Huellein, Jennifer
    Slabicki, Mikolaj
    Isfort, Ilka
    Cyra, Magdalene
    Berthold, Ruth
    Wardelmann, Eva
    Huss, Sebastian
    Altvater, Bianca
    Rossig, Claudia
    Hafner, Susanne
    Simmet, Thomas
    Stahlberg, Anders
    Aman, Pierre
    Zenz, Thorsten
    Lange, Undine
    Kindler, Thomas
    Scholl, Claudia
    Hartmann, Wolfgang
    Froehling, Stefan
    EMBO MOLECULAR MEDICINE, 2019, 11 (05)
  • [26] Yap1 As a Therapeutic Target in Fibrolamellar Carcinoma
    Jewell, Mark
    Premont, Richard T.
    Gibson, Jason
    Glover, Wayne
    Dinh, Timothy A.
    Wauthier, Eliane L.
    Reid, Lola M.
    Gregory, Simon G.
    Sethupathy, Praveen
    Hsu, David S.
    Diehl, Anna Mae
    HEPATOLOGY, 2018, 68 : 1243A - 1243A
  • [27] SIGNALLING All roads lead to YAP1
    Alderton, Gemma K.
    NATURE REVIEWS CANCER, 2010, 10 (01) : 6 - 6
  • [28] YAP1 Expression in Different Subtypes of Rhabdomyosarcoma
    Siddiqi, Ahsan
    Habeebu, Sultan
    Tsokos, Maria
    Ahmed, Atif
    MODERN PATHOLOGY, 2017, 30 : 24A - 24A
  • [29] Requirement for YAP1 signaling in myxoid liposarcoma
    Trautmann, Marcel
    Cheng, Ya-Yun
    Jensen, Patrizia
    Azoitei, Ninel
    Brunner, Ines
    Huellein, Jennifer
    Slabicki, Mikolaj
    Isfort, Ilka
    Cyra, Magdalene
    Wardelmann, Eva
    Huss, Sebastian
    Altvater, Bianca
    Rossig, Claudia
    Hafner, Susanne
    Simmet, Thomas
    Stahlberg, Anders
    Aman, Pierre
    Zenz, Thorsten
    Lange, Undine
    Kindler, Thomas
    Scholl, Claudia
    Hartmann, Wolfgang
    Froehling, Stefan
    CANCER RESEARCH, 2019, 79 (13)
  • [30] YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition (vol 70, pg 55, 2021)
    Ajani, J. A.
    Xu, Y.
    Huo, L.
    GUT, 2021, 70 (05) : E1 - E2